Home Dermatology December 2017 Briefing – Dermatology

December 2017 Briefing – Dermatology

Here are what the editors at HealthDay consider to be the most important developments in Dermatology for December 2017. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Atopic Dermatitis Associated With Higher Risk of Skin Cancer

THURSDAY, Dec. 28, 2017 (HealthDay News) — Atopic dermatitis (AD) is associated with an increased risk of developing squamous cell carcinoma (SCC), according to a study published online Dec. 15 in the International Journal of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Criteria Developed for Idiopathic Inflammatory Myopathies

THURSDAY, Dec. 28, 2017 (HealthDay News) — New classification criteria have been developed for idiopathic inflammatory myopathies (IIM), according to an article published in the December issue of Arthritis & Rheumatology.

Abstract
Full Text (subscription or payment may be required)

Dermatologists Often Undervalue Depression, Anxiety in Patients

WEDNESDAY, Dec. 27, 2017 (HealthDay News) — Dermatologists across Europe tend to underestimate mood disorders in their patients, according to a study published online Dec. 16 in the British Journal of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Rituximab Effective for Lupus-Associated Cytopenia

WEDNESDAY, Dec. 27, 2017 (HealthDay News) — Rituximab treatment seems effective for systemic lupus erythematosus (SLE)-associated immune cytopenias, with an overall initial response rate of 86 percent, according to a study published online Dec. 16 in the American Journal of Hematology.

Abstract
Full Text (subscription or payment may be required)

Both Narrowband UVB, Psoralen UVA Helpful for Hand Eczema

TUESDAY, Dec. 26, 2017 (HealthDay News) — Both psoralen ultraviolet A (PUVA) and narrowband ultraviolet B (NBUVB) improve the severity of chronic palmar hand eczema, according to a pilot study published online Dec. 13 in the British Journal of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Swelling, Infection Most Common Side Effects of Injectable Fillers

THURSDAY, Dec. 21, 2017 (HealthDay News) — The most common adverse events associated with injectable fillers are swelling and infection, according to a study published online Dec. 21 in JAMA Facial Plastic Surgery.

Abstract/Full Text (subscription or payment may be required)

Early-Stage Cancer Diagnoses Up With ACA’s Medicaid Expansions

THURSDAY, Dec. 21, 2017 (HealthDay News) — In their first year, the 2014 Medicaid expansions, facilitated by the Affordable Care Act, were associated with an increase in cancer diagnoses, particularly at the early stage, according to a study published online Dec. 21 in the American Journal of Public Health.

Abstract/Full Text (subscription or payment may be required)

Methotrexate, Azathioprine Seem Safe Long-Term for Dermatitis

THURSDAY, Dec. 21, 2017 (HealthDay News) — Methotrexate and azathioprine appear to be effective and safe as maintenance treatments in moderate-to-severe atopic dermatitis for up to five years, according to research published online Dec. 13 in the British Journal of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Herpes Zoster Risk Not Up in Systemically Treated Psoriasis

WEDNESDAY, Dec. 20, 2017 (HealthDay News) — For patients with psoriasis, the risk of herpes zoster (HZ) is not significantly increased for systemically treated patients or for those receiving biologics versus nonbiologics, according to a research letter published online Dec. 20 in JAMA Dermatology.

Abstract/Full Text (subscription or payment may be required)

Rheumatic Diseases Associated With Increased Dementia Risk

WEDNESDAY, Dec. 20, 2017 (HealthDay News) — Patients with various rheumatic diseases have an increased risk of dementia, according to a study published online Dec. 15 in the International Journal of Rheumatic Diseases.

Abstract
Full Text (subscription or payment may be required)

Drug Combo Proves Effective for Pattern Hair Loss in Women

WEDNESDAY, Dec. 20, 2017 (HealthDay News) — Once-daily capsules containing a combination of minoxidil and spironolactone appear to be safe and effective for the treatment of female pattern hair loss (PHL), according to a case-series study published online Dec. 12 in the International Journal of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Microneedling Plus TCA Peel Performs Well in Acne Scarring

WEDNESDAY, Dec. 20, 2017 (HealthDay News) — Microneedling combined with trichloroacetic acid (TCA) peeling is more effective than microneedling by dermaroller plus platelet-rich plasma (PRP) or microneedling alone for treatment of acne scarring, according to a study published online Dec. 10 in the Journal of Cosmetic Dermatology.

Abstract
Full Text (subscription or payment may be required)

Two Cases of Progressive Cutaneous Anthrax Described

TUESDAY, Dec. 19, 2017 (HealthDay News) — Two cases of cutaneous anthrax which started on the right forearm and progressed are described in a case report published online Dec. 12 in the International Journal of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Male U.S. Doctors Receive Higher Values of Industry Payments

MONDAY, Dec. 18, 2017 (HealthDay News) — Male physicians in the United States received higher values of general payments from industry than females in 2015, according to a research letter published online Dec. 18 in JAMA Internal Medicine.

Abstract/Full Text

Long-Term Macrolide Use Linked to Resistant P. Acnes

MONDAY, Dec. 18, 2017 (HealthDay News) — Long-term oral macrolide administration may increase macrolide-resistant Propionibacterium acnes, according to a study published online Dec. 13 in the Journal of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Year One Results Out for Value-Based Payment Modifier Program

MONDAY, Dec. 18, 2017 (HealthDay News) — Almost 30 percent of eligible practices failed to register and report data in the first year of the Physician Value-Based Payment Modifier program, according to a report published in the December issue of Health Affairs.

Abstract/Full Text (subscription or payment may be required)

Doctors Must Report on at Least 1 Patient, 1 Measure for MACRA

FRIDAY, Dec. 15, 2017 (HealthDay News) — In order to meet the 2017 Medicare and CHIP Reauthorization Act (MACRA) participation reporting deadline and avoid a Medicare payment penalty in 2019, physicians must report on at least one patient and one measure by Dec. 31, and submit to Medicare no later than Feb. 28, 2018, according to a report from the American Medical Association (AMA).

More Information

Nerve Injury ID’d After High-Intensity Focused Ultrasound

FRIDAY, Dec. 15, 2017 (HealthDay News) — High-intensity focused ultrasound (HIFU) treatment for skin laxity can cause facial nerve injury, according to a case study published online Nov. 22 in the Journal of Cosmetic Dermatology.

Abstract
Full Text (subscription or payment may be required)

Q-Switched Nd:YAG 1064 nm Laser Can Improve Track Marks

FRIDAY, Dec. 15, 2017 (HealthDay News) — Q-switched Nd:YAG 1064 nm laser treatment may be beneficial for treating linear hyperpigmented streaks on the bilateral forearms, characteristic of heroin use, according to a case report published online Dec. 12 in the International Journal of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Vermilionectomy Has Good Long-Term Outcome for Lip Lesions

THURSDAY, Dec. 14, 2017 (HealthDay News) — Vermilionectomy is effective for treatment of actinic cheilitis (AC) and squamous cell carcinoma (SCC) of the lower lip, according to a research letter published online Dec. 14 in JAMA Facial Plastic Surgery.

Abstract/Full Text (subscription or payment may be required)

Making Insurers Participate in Marketplace Could Cut Volatility

THURSDAY, Dec. 14, 2017 (HealthDay News) — Requiring insurers that participate in Medicare or Medicaid to also participate in Marketplaces in the same geographic area could improve access to insurance, according to a study published in the December issue of Health Affairs.

Abstract/Full Text (subscription or payment may be required)

Day-Care Centers Have More Allergens Than Homes

THURSDAY, Dec. 14, 2017 (HealthDay News) — Mite, mouse, cat, and dog allergens are higher in day-care centers (DCCs) than in homes, according to a study published online Nov. 29 in Allergy.

Abstract
Full Text (subscription or payment may be required)

Serum Homocysteine Higher in Acne Patients

THURSDAY, Dec. 14, 2017 (HealthDay News) — Acne patients have higher levels of serum homocysteine (HCY), according to a study published online Nov. 21 in the Journal of Cosmetic Dermatology.

Abstract
Full Text (subscription or payment may be required)

Findings Could Help Reduce Risk of Calciphylaxis in Renal Disease

WEDNESDAY, Dec. 13, 2017 (HealthDay News) — For patients with late-stage renal disease, the presence of lupus anticoagulant and combined thrombophilias are risk factors for the development of calciphylaxis, according to a study published online Dec. 13 in JAMA Dermatology.

Abstract/Full Text

Atopic Dermatitis Severity Tied to IgG Response to S. Aureus

TUESDAY, Dec. 12, 2017 (HealthDay News) — Atopic dermatitis (AD) disease severity is associated with immunoglobulin G (IgG) responses against Staphylococcus aureus antigens, according to a study published online Nov. 30 in the British Journal of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Deceleration in Health Care Spending Growth in 2016

MONDAY, Dec. 11, 2017 (HealthDay News) — Health care spending growth slowed in 2016 following faster growth in 2014 and 2015, according to research published online Dec. 6 in Health Affairs.

Abstract
Full Text

Obesity May Be Tied to Higher Rosacea Risk in Women

FRIDAY, Dec. 8, 2017 (HealthDay News) — Obesity may be associated with an increased risk for rosacea, according to a study published in the December issue of the Journal of the American Academy of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Platelet-Rich Plasma Injection May Be Effective for Alopecia

THURSDAY, Dec. 7, 2017 (HealthDay News) — Subcutaneous injection of platelet-rich plasma (PRP) may be effective for treating alopecia, according to an experimental study published Nov. 11 in the Journal of Cosmetic Dermatology.

Abstract
Full Text (subscription or payment may be required)

Educational Video Helps Hairdressers Better ID Melanoma

WEDNESDAY, Dec. 6, 2017 (HealthDay News) — A brief educational video could be beneficial for increasing hairdresser knowledge of melanoma and self-confidence in skin lesion detection, according to a research letter published online Dec. 6 in JAMA Dermatology.

Abstract/Full Text (subscription or payment may be required)

CRP Levels Potentially Useful in Chronic Spontaneous Urticaria

WEDNESDAY, Dec. 6, 2017 (HealthDay News) — C-reactive protein (CRP) levels are frequently elevated in patients with chronic spontaneous urticaria (CSU), and these elevations are relevant and potentially useful in management of the condition, according to a study published online Nov. 12 in Allergy.

Abstract
Full Text (subscription or payment may be required)

CVS-Aetna Merger Has Implications for Doctors’ Offices

TUESDAY, Dec. 5, 2017 (HealthDay News) — CVS Health’s planned purchase of insurance giant Aetna, a $69 billion deal, was announced Sunday.

More Information – NYT
More Information – HealthDay

Doctor Density Linked to Billing for Dermatology Procedures

MONDAY, Dec. 4, 2017 (HealthDay News) — Higher dermatologist density is associated with increased use of dermatology procedures and billing to Medicare, according to a study published online Nov. 29 in JAMA Dermatology.

Abstract/Full Text

Relevant Health Care Price Info Hard to Find Online

MONDAY, Dec. 4, 2017 (HealthDay News) — Overall, 17 percent of websites provide geographically relevant health care price estimates relating to specific interventions, according to a research letter published online Dec. 4 in JAMA Internal Medicine.

Abstract/Full Text (subscription or payment may be required)

Copyright © 2018 ScoutNews, LLC. All rights reserved.